Current Approach to the Diagnosis and Management of Portopulmonary Hypertension

Lynn A. Fussner, Michael Joseph Krowka

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Portopulmonary hypertension (POPH) is a form of pulmonary arterial hypertension occurring in the setting of portal hypertension with or without hepatic cirrhosis. The presence of both portal and pulmonary vascular disease contributes to complicated hemodynamics and therapeutic challenges, though the severities do not appear to correlate directly. Diagnosis of POPH, and distinction from the commonly observed hyperdynamic state of end-stage liver disease, is typically accomplished with an initial screening transthoracic echocardiogram, followed by right heart catheterization for confirmation of hemodynamic parameters. Though few studies have directly evaluated use in POPH, pulmonary artery-directed therapy is the cornerstone of management, along with consideration of liver transplantation. Perioperative and long-term outcomes are variable, but uniformly worse in the setting of uncontrolled pulmonary pressures. Risk stratification and optimal patient selection for these interventions are areas of ongoing investigation.

Original languageEnglish (US)
Article number29
JournalCurrent Gastroenterology Reports
Volume18
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Hypertension
Hemodynamics
End Stage Liver Disease
Portal Hypertension
Cardiac Catheterization
Vascular Diseases
Pulmonary Hypertension
Liver Cirrhosis
Liver Transplantation
Patient Selection
Pulmonary Artery
Lung Diseases
Pressure
Lung
Therapeutics

Keywords

  • Echocardiography
  • Liver transplant
  • Portopulmonary hypertension
  • Pulmonary arterial hypertension
  • Right heart catheterization
  • Vasodilator

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Current Approach to the Diagnosis and Management of Portopulmonary Hypertension. / Fussner, Lynn A.; Krowka, Michael Joseph.

In: Current Gastroenterology Reports, Vol. 18, No. 6, 29, 01.06.2016.

Research output: Contribution to journalArticle

@article{d348e2aa15b74ee68d8c143383db9296,
title = "Current Approach to the Diagnosis and Management of Portopulmonary Hypertension",
abstract = "Portopulmonary hypertension (POPH) is a form of pulmonary arterial hypertension occurring in the setting of portal hypertension with or without hepatic cirrhosis. The presence of both portal and pulmonary vascular disease contributes to complicated hemodynamics and therapeutic challenges, though the severities do not appear to correlate directly. Diagnosis of POPH, and distinction from the commonly observed hyperdynamic state of end-stage liver disease, is typically accomplished with an initial screening transthoracic echocardiogram, followed by right heart catheterization for confirmation of hemodynamic parameters. Though few studies have directly evaluated use in POPH, pulmonary artery-directed therapy is the cornerstone of management, along with consideration of liver transplantation. Perioperative and long-term outcomes are variable, but uniformly worse in the setting of uncontrolled pulmonary pressures. Risk stratification and optimal patient selection for these interventions are areas of ongoing investigation.",
keywords = "Echocardiography, Liver transplant, Portopulmonary hypertension, Pulmonary arterial hypertension, Right heart catheterization, Vasodilator",
author = "Fussner, {Lynn A.} and Krowka, {Michael Joseph}",
year = "2016",
month = "6",
day = "1",
doi = "10.1007/s11894-016-0504-2",
language = "English (US)",
volume = "18",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Current Approach to the Diagnosis and Management of Portopulmonary Hypertension

AU - Fussner, Lynn A.

AU - Krowka, Michael Joseph

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Portopulmonary hypertension (POPH) is a form of pulmonary arterial hypertension occurring in the setting of portal hypertension with or without hepatic cirrhosis. The presence of both portal and pulmonary vascular disease contributes to complicated hemodynamics and therapeutic challenges, though the severities do not appear to correlate directly. Diagnosis of POPH, and distinction from the commonly observed hyperdynamic state of end-stage liver disease, is typically accomplished with an initial screening transthoracic echocardiogram, followed by right heart catheterization for confirmation of hemodynamic parameters. Though few studies have directly evaluated use in POPH, pulmonary artery-directed therapy is the cornerstone of management, along with consideration of liver transplantation. Perioperative and long-term outcomes are variable, but uniformly worse in the setting of uncontrolled pulmonary pressures. Risk stratification and optimal patient selection for these interventions are areas of ongoing investigation.

AB - Portopulmonary hypertension (POPH) is a form of pulmonary arterial hypertension occurring in the setting of portal hypertension with or without hepatic cirrhosis. The presence of both portal and pulmonary vascular disease contributes to complicated hemodynamics and therapeutic challenges, though the severities do not appear to correlate directly. Diagnosis of POPH, and distinction from the commonly observed hyperdynamic state of end-stage liver disease, is typically accomplished with an initial screening transthoracic echocardiogram, followed by right heart catheterization for confirmation of hemodynamic parameters. Though few studies have directly evaluated use in POPH, pulmonary artery-directed therapy is the cornerstone of management, along with consideration of liver transplantation. Perioperative and long-term outcomes are variable, but uniformly worse in the setting of uncontrolled pulmonary pressures. Risk stratification and optimal patient selection for these interventions are areas of ongoing investigation.

KW - Echocardiography

KW - Liver transplant

KW - Portopulmonary hypertension

KW - Pulmonary arterial hypertension

KW - Right heart catheterization

KW - Vasodilator

UR - http://www.scopus.com/inward/record.url?scp=84964260996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964260996&partnerID=8YFLogxK

U2 - 10.1007/s11894-016-0504-2

DO - 10.1007/s11894-016-0504-2

M3 - Article

C2 - 27098816

AN - SCOPUS:84964260996

VL - 18

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 6

M1 - 29

ER -